NCT06488261View on ClinicalTrials.gov

Long Term Follow-Up for Safety of AVR-RD-02

Active, not recruitingOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

June 30, 2037

Study Completion Date

October 31, 2037

Conditions
Gaucher Disease
Interventions
BIOLOGICAL

AVR-RD-02

No study drug is administered in this study. Subjects who received AVR-RD-02 in a separate parent trial will be evaluated in this trial for long-term safety.

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
lead

John Bernat

OTHER

NCT06488261 - Long Term Follow-Up for Safety of AVR-RD-02 | Biotech Hunter | Biotech Hunter